Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in <i>TP53</i> -mutated advanced biliary tract cancer.Taro Shibuki, Masafumi Ikeda, Celine Hoyek et al.|Journal of Clinical Oncology|2025Cited by 0
Targeted Therapy Improves Real-World Survival in Patients with Molecularly Matched Advanced Biliary Tract CancerTanios Bekaii‐Saab, Masafumi Ikeda, Binbin Zheng-Lin et al.|Research Square|2025Cited by 0
Prognostic role of PIK3CA and co-alterations in advanced biliary tract cancer: A multicenter retrospective analysis.Oluseyi Abidoye, Tanios S. Bekaii-Saab, Mitsuho Imai et al.|Journal of Clinical Oncology|2026Cited by 0
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysisBinbin Zheng-Lin, Tanios Bekaii-Saab, Taro Shibuki et al.|npj Precision Oncology|2026Cited by 0
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancerTaro Shibuki, Masafumi Ikeda, Celine Hoyek et al.|Journal of Gastroenterology|2026Cited by 0